Biomarker analysis of patients with follicular lymphoma treated with ibrutinib in the phase 2 DAWN study. (June 2017)

• Record Type: Journal Article
• Authors: Fowler, N.; Gopal, A.K.; Schuster, S.J.; Trotman, J.; Hess, G.; Hou, J.; Yacoub, A.; Lill, M.; Martin, P.; Vitolo, U.; Spencer, A.; Radford, J.; Jurczak, W.; Morton, J.; Osmanov, D.; Caballero, D.; Deshpande, S.; Vermeulen, J.; Damle, R.; Schaffer, M.; Balasubramanian, S.; Cheson, B.; Salles, G.
• Is Part Of: Hematological oncology. Volume 35(2017)Supplement 2
• Page Start: 210
• Page End: 211
• Publication Date: 2017-06
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.2438_75
• Languages: English
• ISSNs: 0278-0232